Injection solution Composition:

Injection solution: 1.1 ml cont.: Origanum vulgare D6, Origanum vulgare D10, Origanum vulgare D30 6.6 µl each; Erythraea centaurium D10, Erythraea centaurium D30 4.4 µl each.


Ulcus ventriculi et duodeni.


In acute disorders 1 ampoule daily, otherwise 3-1 times weekly i.m., s.c., i.d., i.v. Package sizes:

Packs containing 5, 10, 50 and 100 ampoules of 1.1 ml.

Pharmacological and clinical notes

Origanum vulgare (marjoram)

Gastro-intestinal catarrh (with or without ulceration), antispasmodic. Erythraea centaurium (centaury)

Gastric, hepatic and biliary disorders, antipyretic.

Based on the individual homoeopathic constituents of Erigotheel, therapeutical possibilities result for the treatment of ventricular and duodenal ulcers, hyperacidity, parapyloric syndrome according to Strauss = irritation triad: hyperaesthesis, supersecretion and hypermotility of the stomach.

As the bitter principles contained in both components of the preparation are able to increase the excitability of the sympathetic nervous system, the effect of Erigotheel is essentially conditioned by the indirect alleviation of the vagotonia caused by the stimulation of the antagonistic sympathetic nervous system. In addition to a mild spasmolysis, Erigotheel leads to a biological regulation of the secretory function of the gastroduodenal mucosa, creating the necessary physiological conditions for curing an ulcer, which are also of great significance in preventing recurrent ulcers. Also chronic ulcers and the dumping syndrome can be favourably influenced therapeutically by Erigotheel.

The dosage is adjusted according to the disease, the clinical picture and the stage of the illness: Erigotheel is advantageously administered over a fairly long period, during which 3 injections (i.m., s.c., i.v.) are given weekly in the form of segmental therapy, in

the skin of the right side of the epigastrium, or paravertebrally. In acute disorders or as initial treatment, daily injections for several days.

Combination with Traumeel S in an i.v. or i.m. mixed injection enhances the therapeutical success.

For particularly therapy-resistant cases it is recommended, in addition to an Erigotheel- Traumeel S mixed injection to be administered every 2 days i.v. or i.m., on the intervening days to administer 1 ampoule of Erigotheel in the hyperesthetic zones in the form of wheals or injected s.c.

The additional oral therapeutic agent is Duodenoheel (1 tablet 3 times daily); in chronic cases Anacardium-Homaccord; where there is a suspicion of precancerous state, Galium-Heel, etc.